Derio, Spain · Founded 2009 · Privately Held (backing)
Developer of stroma-targeted precision drugs and diagnostics intended to fight against invasive tumours. Oncomatryx Biopharma is based in Derio, Spain and was founded in 2009. Its last reported valuation was $112 million in Mar 2022. It has raised $146 million.
Last reported valuation
$111.8M
Oct 2026
Priced at
—
Total raised
$146.0M
Last round
—
Team — not yet on record
No current team members for Oncomatryx Biopharma are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Oncomatryx Biopharma with a free account
·Watch Oncomatryx Biopharma: the Monday email on marks, rounds and moves
